CAR-T SynKIR-310

FDA clears IND for Verismo Therapeutics’ CAR-T therapy
Clinical Trials Arena
Wed, 05/15/24 - 11:29 am
Verismo Therapeutics
CAR-T SynKIR-310
FDA
clinical trials
relapsed or refractory B cell lymphoma